CVS - CVS Health Corporation (CVS) Q4 2023 Earnings Call Transcript
2024-02-07 11:55:02 ET
CVS Health Corporation (CVS)
Q4 2023 Earnings Conference Call
February 7, 2024 8:00 AM ET
Company Participants
Larry McGrath - Senior Vice President, Business Development and Investor Relations
Karen Lynch - President and Chief Executive Officer
Tom Cowhey - Chief Financial Officer
Brian Kane - Executive Vice President and President, Aetna
Prem Shah - Executive Vice President, Chief Pharmacy Officer and President, Pharmacy and Consumer Wellness
Mike Pykosz - Executive Vice President and President of Health Care Delivery
Conference Call Participants
Lisa Gill - JP Morgan
Justin Lake - Wolfe Research
Kevin Caliendo - UBS
Nathan Rich - Goldman Sachs
Ann Hynes - Mizuho
Josh Raskin - Nephron Research
Elizabeth Anderson - Evercore ISI
Stephen Baxter - Wells Fargo
Allen Lutz - Bank of America
Charles Rhyee - TD Cowen
John Ransom - Raymond James
Erin Wright - Morgan Stanley
Presentation
Operator
Good morning or good afternoon, all and welcome to the CVS Health Q4 2023 Earnings Results Call. My name is Adam, and I'll be your operator today. [Operator Instructions]
I will now hand the floor to Larry McGrath to begin. So Larry, please go ahead when you are ready.
Larry McGrath
Good morning, and welcome to the CVS Health fourth quarter 2023 earnings call and webcast. I'm Larry McGrath, Senior Vice President of Business Development and Investor Relations for CVS Health. I'm joined this morning by Karen Lynch, President and Chief Executive Officer; and Tom Cowhey, Chief Financial Officer.
Following our prepared remarks, we'll host a question-and-answer session that will include additional members of our leadership team. Our press release and slide presentation are being posted to our website, along with our Form 10-K filed this morning with the SEC. Today's call is also being broadcast on our website, where it will be archived for one year.
During this call, we will make certain forward-looking statements. Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties. In particular, those that are described in the cautionary statement concerning forward-looking statements and risk factors in our Form 10-K we filed this morning....
CVS Health Corporation (CVS) Q4 2023 Earnings Call Transcript